Loading ...

Stock Quote vvus

vvus Stock Price Today

vvus Price History

vvus Stock Price History

vvus History

Last Price vvus

Close Price vvus

Day Change vvus

After Hours Quote vvus

Open Price vvus

Day Range vvus

Year Range vvus

Projected Yield vvus

Market Cap vvus

Stock Volume vvus

Average Volume vvus

Forward Price vvus

PE for vvus

PB for vvus

PS for vvus

PCF for vvus

price earnings ratio vvus

price to book ratio vvus

price to sales ratio vvus

price to cash flow ratio vvus

Stock Quote Vivus

Vivus Stock Price today

Vivus Price history

Vivus Stock Price history

Vivus history

Last Price Vivus

Close Price Vivus

Day Change Vivus

After Hours Quote for Vivus

Open Price Vivus

Day Range Vivus

Year Range Vivus

Projected Yield Vivus

Market Cap Vivus

Stock Volume Vivus

Average Volume Vivus

Forward Price Vivus

pe Vivus

pb Vivus

ps Vivus

pcf Vivus

price earnings ratio Vivus

price to book ratio Vivus

price to sales ratio Vivus

price to cash flow ratio Vivus

What Does This Company Do?
VIVUS is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Distressed
Employees
98
Stock Style
Small Core

Key Stats  VVUS More...

Key Stats VVUS

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center

News  vvus - Vivus More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Related Topics

Analysis  vvus - Vivus More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports vvus - VivusMore...

Click above to view more mutual fund data and stats for vvus - Vivus.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   VVUS More ...

Ownership VVUS

SPDR® S&P Pharmaceuticals ETF
Vanguard Small Cap Index
Vanguard Total Stock Mkt Idx
iShares US Pharmaceuticals
iShares Nasdaq Biotechnology

Wall St. Recommendations  vvus - Vivus More...

Wall Street Analyst Recommendation VVUS

Stock Price Quote: vvus Vivus - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: 3454 - Vivotek Inc  |  Next: vvus - Vivus